Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A clinical trial for NSI-566 in chronic stroke in China

Trial Profile

A clinical trial for NSI-566 in chronic stroke in China

Phase of Trial: Phase I

Latest Information Update: 22 May 2018

At a glance

  • Drugs NSI 566 (Primary)
  • Indications Stroke
  • Focus Adverse reactions
  • Most Recent Events

    • 22 May 2018 New trial record
    • 15 May 2018 According to a Neuralstem media release, this study may expected to start in mid-2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top